UCB S.A.
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
公司地址 Allee de la Recherche, 60, Brussels, BEL, B-1070
電話號碼 +32 25599999
傳真號碼 +32 25599900
公司網頁 https://www.ucb.com
員工數量 10117
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jean-Christophe Tellier Director and Chief Executive Officer -- 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Ulf Wiinberg Independent Director 25/02/2026
Mr. Jonathan M. Peacock Chairman of the Board 25/02/2026
Mr. Jean-Christophe Tellier Director and Chief Executive Officer 25/02/2026
Dr. Jan Berger Independent Director 25/02/2026
Dr. Dolca Thomas, M.D. Independent Director 25/02/2026
Ms. Maelys Castella Independent Director 25/02/2026
Ms. Kay Davies Independent Director 25/02/2026
Mr. Pierre L. Gurdjian Independent Director 25/02/2026
Mr. Charles-Antoine Janssen Vice Chairman of the Board 25/02/2026
Mr. Stef Heylen Independent Director 25/02/2026
Mr. Cedric van Rijckevorsel Director 25/02/2026
Mr. Rodolfo J. Savitzky Independent Director 25/02/2026
Mr. Cyril Janssen Director 25/02/2026
Ms. Fiona Powrie Independent Director 25/02/2026
Ms. Nefertiti Greene Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
AVIVAvantis International Large Cap Val ETF0.005%28/02/2026
TOUST. Rowe Price International Equity ETF0.005%28/02/2026
EWKiShares MSCI Belgium ETF0.004%28/02/2026
FMEDFidelity Disruptive Medicine ETF0.004%27/02/2026
WWJDInspire International ETF0.004%27/02/2026
GSIEGoldman Sachs ActiveBeta® Intl Eq ETF0.004%27/02/2026
DFSIDimensional International Sstby Cr 1 ETF0.004%27/02/2026
FDTFirst Trust Dev Mkts Ex-US AlphaDEX® ETF0.004%26/02/2026
HFXINYLI FTSE International Eq Ccy Netrl ETF0.003%30/01/2026
SPEUState Street® SPDR® Portfolio Europe ETF0.003%27/02/2026
DBEUXtrackers MSCI Europe Hedged Equity ETF0.003%24/02/2026
BKIEBNY Mellon International Equity ETF0.003%28/02/2026
PXFInvesco RAFI Developed Markets ex-US ETF0.003%24/02/2026
GSIDGoldman Sachs MarketBeta Intl Eq ETF0.003%24/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.003%27/02/2026
QEFAState Street® SPDR® MSCI EAFE StrtFcsETF0.002%27/02/2026
DDWMWisdomTree Dynamic International Eq ETF0.002%27/02/2026
FEUZFirst Trust Eurozone AlphaDEX® ETF0.002%26/02/2026
QINTAmerican Century Quality Dvrs Intl ETF0.002%28/02/2026
RODMHartford Multifactor Dev Mkts (exUS) ETF0.002%28/02/2026
  1    2   3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.